Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
3,877 articles
📰
Outlook Therapeutics Announces Proposed Public Offering
ISELIN, N.J., March 23, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company focused on enhancing the...
📰
Globus Medical Announces Board Departure
AUDUBON, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced...
BLRX: Full Year 2025 Results
By John Vandermosten, CFA
NASDAQ: BLRX
READ THE FULL BLRX RESEARCH REPORT
BioLineRx Ltd. (NASDAQ: BLRX) reported 2025 financial and operational...
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
SINTX Technologies (NASDAQ:SINT) shares rose 5.9% to $2.7 during Monday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
SINTX Technologies (NASDAQ:SINT) shares rose 5.9% to $2.7 during Monday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
SINTX Technologies (NASDAQ:SINT) shares rose 5.9% to $2.7 during Monday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
SINTX Technologies (NASDAQ:SINT) shares rose 5.9% to $2.7 during Monday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
SINTX Technologies (NASDAQ:SINT) shares rose 5.9% to $2.7 during Monday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
SINTX Technologies (NASDAQ:SINT) shares rose 5.9% to $2.7 during Monday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
SINTX Technologies (NASDAQ:SINT) shares rose 5.9% to $2.7 during Monday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
SINTX Technologies (NASDAQ:SINT) shares rose 5.9% to $2.7 during Monday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
SINTX Technologies (NASDAQ:SINT) shares rose 5.9% to $2.7 during Monday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
SINTX Technologies (NASDAQ:SINT) shares rose 5.9% to $2.7 during Monday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
SINTX Technologies (NASDAQ:SINT) shares rose 5.9% to $2.7 during Monday's after-market session. The market value of their outstanding...
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
SINTX Technologies (NASDAQ:SINT) shares rose 5.9% to $2.7 during Monday's after-market session. The market value of their outstanding...
Ondas, GameStop, PDD and More Stocks With Earnings This Week
The current earnings season is winding down, but there are still some retail investors’ favorites reporting this week.
ONDS stock is up after...
📰
Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results
Daix (France), New York (United States), March 23, 2026 – Inventiva (NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical...
Perimeter Schedules Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 31st; Provides Corporate Update
TORONTO and DALLAS, March 23, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a...
📰
If You Only Own Tech Stocks, Jim Cramer Has a Blunt Warning for You in 2026
CNBC commentator Jim Cramer sees value in the artificial intelligence (AI) realm beyond the technology sector.
📰
Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results
Daix (France), New York (United States), March 23, 2026 – Inventiva (NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical...
Bionano Genomics Stock Soars As Efficiency Gains Meet Growth Story
Bionano Genomics (NASDAQ:BNGO) just pulled back the curtain on its fourth-quarter results, and the message is clear: the company is getting leaner...
Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) will release earnings results for its fourth quarter, before the opening bell on Tuesday, March...
Applied Optoelectronics (AAOI) Stock Rises On New Order From Major Hyperscaler
Applied Optoelectronics Inc (NASDAQ:AAOI) shares are trading higher in Monday’s after-hours session after the company announced a new order...
📰
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
Monday, March 30: Phase 1 data on TNX-4800 (long-acting anti-Borrelia OspA human monoclonal antibody) for the seasonal prevention of Lyme...
📰
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
Monday, March 30: Phase 1 data on TNX-4800 (long-acting anti-Borrelia OspA human monoclonal antibody) for the seasonal prevention of Lyme disease
📰
Should You Buy Bristol Myers Squibb Stock for Its 4.4%-Yielding Dividend?
The healthcare company has been a top dividend growth stock for years.
📰
Context Therapeutics Reports Full Year 2025 Operating and Financial Results
Phase 1a interim data for ongoing trial of CTIM-76 (CLDN6 x CD3) expected in June 2026
Phase 1a interim data for ongoing trial of CT-95 (MSLN x CD3)...
📰
Context Therapeutics Reports Full Year 2025 Operating and Financial Results
Phase 1a interim data for ongoing trial of CTIM-76 (CLDN6 x CD3) expected in June 2026
📰
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
– Dosed three cohorts in Phase 1 trial of STRO-004, potential best-in-class Tissue Factor (TF) ADC; on track to report initial clinical data in...
📰
Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
ABTECT Phase 3 Data Safety Monitoring Board (DSMB) meeting on March...
📰
Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update
📰
Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Voluntary pause of the Phase 3 HERO and OLE trials evaluating ARD-101 for the treatment of hyperphagia in individuals with Prader-Willi Syndrome,...
📰
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
– Dosed three cohorts in Phase 1 trial of STRO-004, potential best-in-class Tissue Factor (TF) ADC; on track to report initial clinical data in...
📰
Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Expect to submit an Investigational New Drug application for SZN-8141 to FDA in the second half of 2026
Scheduled to present retinal vascular...
📰
Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting
BRISBANE, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (NASDAQ:NRIX), a clinical-stage biopharmaceutical company focused on...
📰
Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
📰
Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026
Conference call today, March 23, 2026, at 4:30 PM ET Conference call today, March 23, 2026, at 4:30 PM ET